Two Sigma Advisers
PMVP icon

Two Sigma Advisers’s PMV Pharmaceuticals PMVP Stock Holding History

Two Sigma Advisers’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-874,100
Closed -$1.09M – 1594
2025
Q4 		$1.09M Buy
874,100
+456,200
+109% +$611K ﹤0.01% 1445
2025
Q3 		$585K Sell
417,900
-67,800
-14% -$93.8K ﹤0.01% 1701
2025
Q2 		$515K Sell
485,700
-19,900
-4% -$19.5K ﹤0.01% 1735
2025
Q1 		$551K Sell
505,600
-209,000
-29% -$284K ﹤0.01% 1736
2024
Q4 		$1.08M Sell
714,600
-36,600
-5% -$58K ﹤0.01% 1422
2024
Q3 		$1.12M Buy
751,200
+257,700
+52% +$398K ﹤0.01% 1363
2024
Q2 		$799K Buy
493,500
+128,100
+35% +$231K ﹤0.01% 1669
2024
Q1 		$621K Buy
365,400
+176,800
+94% +$330K ﹤0.01% 1777
2023
Q4 		$585K Buy
188,600
+149,800
+386% +$396K ﹤0.01% 1854
2023
Q3 		$238K Sell
38,800
-63,900
-62% -$439K ﹤0.01% 2052
2023
Q2 		$643K Buy
102,700
+47,800
+87% +$250K ﹤0.01% 1714
2023
Q1 		$262K Buy
+54,900
New +$386K ﹤0.01% 2189
2022
Q2 		– Sell
-28,100
Closed -$585K – 2836
2022
Q1 		$585K Sell
28,100
-6,400
-19% -$113K ﹤0.01% 1906
2021
Q4 		$797K Buy
+34,500
New +$834K ﹤0.01% 1683

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers's PMVP Position: Q1 2026 in Review

Two Sigma Advisers sold out of PMV Pharmaceuticals (PMVP) in Q1 2026, closing a stake of 874,100 shares — an estimated $1.09M sold.

Two Sigma Advisers first reported a position in PMVP in Q4 2021 and held it in 14 quarters. The position peaked at $1.12M in Q3 2024. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Two Sigma Advisers reported no remaining PMV Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 874,100 PMV Pharmaceuticals shares in Q1 2026, an estimated $1.09M.
  • Two Sigma Advisers first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Two Sigma Advisers's PMV Pharmaceuticals position peaked at $1.12M in Q3 2024.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.